Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker NVAX
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 5, 2026 | NVAX Novavax, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 29, 2026 | NVAX Novavax, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 29, 2026 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 6, 2026 | NVAX Novavax, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 23, 2026 | NVAX Novavax, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 6, 2026 | NVAX Novavax, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 26, 2026 | NVAX Novavax, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 20, 2026 | NVAX Novavax, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 12, 2026 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | NVAX Novavax, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 6, 2025 | NVAX Novavax, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 4, 2025 | NVAX Novavax, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 4, 2025 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 22, 2025 | NVAX Novavax, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 22, 2025 | NVAX Novavax, Inc. | 2.06 Material Impairments | 8-K | 8-K ↗ |
| Oct 22, 2025 | NVAX Novavax, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 7, 2025 | NVAX Novavax, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 7, 2025 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 27, 2025 | NVAX Novavax, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Aug 27, 2025 | NVAX Novavax, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Aug 27, 2025 | NVAX Novavax, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 27, 2025 | NVAX Novavax, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 27, 2025 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 21, 2025 | NVAX Novavax, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 21, 2025 | NVAX Novavax, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Aug 21, 2025 | NVAX Novavax, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 6, 2025 | NVAX Novavax, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 24, 2025 | NVAX Novavax, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 11, 2025 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 27, 2025 | NVAX Novavax, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 19, 2025 | NVAX Novavax, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 19, 2025 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 8, 2025 | NVAX Novavax, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 5, 2025 | NVAX Novavax, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 29, 2025 | NVAX Novavax, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Apr 23, 2025 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 2, 2025 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 11, 2025 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 11, 2025 | NVAX Novavax, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 11, 2025 | NVAX Novavax, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 4, 2025 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 27, 2025 | NVAX Novavax, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 13, 2025 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 13, 2025 | NVAX Novavax, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 30, 2024 | NVAX Novavax, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Dec 18, 2024 | NVAX Novavax, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 4, 2024 | NVAX Novavax, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 20, 2024 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2024 | NVAX Novavax, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 12, 2024 | NVAX Novavax, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:15 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances